In April 2022 it was announced that (for an undisclosed amount), Theracell Inc had been acquired by Isto Biologics - a surgical-based, osteo-biologic regeneration technologies and cell-based therapies that is a portfolio company of the private equity firm Thompson Street Capital Partners (TSCP) based in St. Louis, MO. Announcement of the transaction included the observation that the acquisition will strengthen Istoâs focus on offering extraordinary solutions for surgical and clinical care procedures within spine, orthopedics, and sports medicine. TheraCell, Inc.,-- a California-based regenerative medicine company. With facilities in Northridge CA and research labs in Littleton MA, -- is organized around advancement of technology developed at the Hebrew University - specically a stem cell sorting device to concentrate MSCâs from adipose tissue and Oxygenation technology to improve survival of stem cell solutions. Guided by a team of influential spine surgeons, and led by experienced Medical Device executives, TheraCell has further developed methodologies and gained patent protection for applying the oxygenation technology to demineralized bone matrix products. The firm has also developed a proprietary, patent pending process for the production of demineralized bone fibers. The firm's DBF⢠technology has enabled development of a number of Fiber Matrix⢠products. The firm also has a proprietary, patent pending process to enhance the osteoinductivity of demineralized cancellou
